Self-Amplifying RNA Cell Reprogramming Through Membrane Perturbation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for cell reprogramming, such as iPSC differentiation and somatic cell transdifferentiation, are inefficient, cumbersome, and costly, often resulting in heterogeneous cell populations and pose risks like insertional mutagenesis and cytotoxicity.
Innovation Solution
A method involving passing a cell suspension through a constriction to perturb the cell membrane, allowing self-amplifying RNA encoding a reprogramming factor to enter and express, enhancing expression and reprogramming efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If lentiviral vectors are used for reprogramming, then reprogramming efficiency is improved, but the risk of insertional mutagenesis increases
Solution Approach 1:
The patent extracts the reprogramming function from viral vectors and implements it using a non-integrating RNA-based system. The self-amplifying RNA delivers reprogramming factors without integrating into the host genome, thereby maintaining high reprogramming efficiency while eliminating insertional mutagenesis risk.
Solution Approach 2:
The patent uses self-amplifying RNA as an intermediary to deliver reprogramming factors. This RNA-based mediator temporarily expresses the required factors without permanent genetic modification, achieving the reprogramming goal without the harmful effects of viral integration.
2Productivity
If electroporation or lipofection methods are used to deliver reprogramming factors, then delivery efficiency is improved, but cell health and recovery are negatively affected
Solution Approach 1:
The patent replaces mechanical delivery methods (electroporation, lipofection) with a passive diffusion-based RNA delivery system. The self-amplifying RNA naturally enters cells through membrane perturbation or endocytosis without requiring harsh mechanical or chemical treatments, thereby maintaining high delivery efficiency while preserving cell health.
3Adaptability or versatility
If iPSC differentiation methods are used, then various cell types can be produced, but the process time increases to several weeks or months
Solution Approach 1:
The patent uses self-amplifying RNA to deliver multiple reprogramming factors simultaneously, preparing the cells in advance for direct transdifferentiation. This preliminary delivery of all necessary factors enables direct conversion between cell types without the time-consuming multi-stage iPSC differentiation process.
Solution Approach 2:
Instead of following the conventional path of differentiation through iPSC intermediates, the patent inverts the approach by using direct reprogramming. The self-amplifying RNA system enables direct transdifferentiation from one somatic cell type to another, reversing the traditional differentiation pathway and dramatically reducing time.
4Reliability
If conventional reprogramming methods are used, then reprogramming can be achieved, but the resulting cell population is heterogeneous
Solution Approach 1:
The patent uses self-amplifying RNA to deliver a standardized set of reprogramming factors to all target cells uniformly. This homogeneous delivery approach, combined with direct reprogramming protocols, produces highly uniform cell populations with consistent differentiation outcomes, eliminating the heterogeneity associated with conventional methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves increased and sustained expression of reprogramming factors, leading to more efficient and cost-effective cell reprogramming with minimal cytotoxicity, producing homogeneous cell populations.
Implementation Method 1
passing the cell suspension through the constriction under the set of parameters causes a perturbation within the membrane of the cell
Data Source
AI summary
The present disclosure provides methods for reprogramming a cell, wherein the method comprises passing a cell suspension comprising the cell and a self-amplifying RNA encoding a reprogramming factor through a constriction, wherein the constriction deforms the cell, thereby causing a perturbation of the cell such that the reprogramming factor enters the cell.